Researchers report progress in looking for signs of lung cancer in the blood.

The research team led by Senior Researchers Yoonhee Lee from the Division of Biomedical Technology and Gyogwon Koo from the Division of Intelligent Robot at DGIST (under President Kunwoo Lee) has ...

In an era where targeted therapies and immunotherapy are reshaping first-line treatment, the stakes of getting the workup right—and getting it right the first time—have never been higher. This ...

SOPHiA GENETICS (NASDAQ: SOPH), a global leader in Ai-driven precision medicine, today announced a partnership with Synnovis, ...

Heather Quintana Suchan says early biomarker testing at diagnosis helped match her to Rybrevant and urges patients to personalize care and stay active during treatment. Heather Quintana Suchan, a ...

Randomized Phase III Trial for Evaluating the Efficacy of Adjuvant Abemaciclib in Patients With Locoregional Recurrence of Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative ...

Lung adenocarcinoma is the most common type of lung cancer diagnosed in the U.S. Just over half of all non-small-cell lung cancers (NSCLCs) are adenocarcinomas. Finding out that you're at risk of lung ...

Synnovis and SOPHiA GENETICS partner to bring blood-based cancer testing to patients across UK: London, United Kingdom Friday, May 15, 2026, 12:00 Hrs [IST] SOPHiA GENETICS, a glo ...